Weight Loss With Type 2 Diabetes? What Ontario Patients Need to Know
First things first: Can you lose weight with type 2 diabetes? Yes, you can.
Now that we’ve got that out of the way, let’s just preface by saying that it’s harder to lose weight with type 2 diabetes than it is for someone without it, and that has nothing to do with willpower. So, if you’ve been struggling to lose weight with type 2 diabetes and doubting your willpower or your discipline then know this: Your body is fighting the same fight you are, only from the “other side”. Once that clicks, the whole thing stops feeling like a personal failing.
So many people with type 2 diabetes get unfairly, and unsympathetically, told to “just lose some weight” to sort out their blood sugar. However, when people with type 2 diabetes try to lose weight the “conventional way”, the scale just sits there like a parked car. If that’s something you’ve experienced then keep reading.
The good news? There’s a fix, and we’ll be discussing it in this blog, along with expert tips, guidance, myths, expectations and weight loss medications, from Khalid Bhatti, M.PHARM, R.PH., CDE, Director of Pharmacy & Diabetes Education, Durham Care Clinic + Pharmacy.
The Loop That Keeps The Scale Stuck
Insulin is the hormone that lets your cells pull glucose out of your blood and either burn it for energy or tuck it away for later, some as glycogen, some as fat. It does one more thing people forget: while insulin is high, it puts the brakes on fat burning.
In type 2 diabetes, the cells stop responding to that signal properly. Glucose struggles to get in, so it lingers in the bloodstream, and the pancreas answers by pumping out even more insulin to force the point. That’s the part that makes weight loss so stubborn for people suffering from type 2 diabetes. Because all that circulating insulin keeps your body in storage mode and locks the door on fat burning, while your cells, still short on usable fuel, leave you hungry and tired.
This is often called “insulin resistance”, and it traps people with type 2 diabetes in a vicious weight-gain loop: high insulin, easy storage, hard loss. Layer on the fact that some diabetes medications themselves cause weight gain, and people with type 2 really are fighting an uphill battle when it comes to weight gain. This is a battle that you cannot win following diet plans, exercises and lifestyle modifications that work for nondiabetic people. What you need is specialized guidance and plans to lose weight with type 2 diabetes.
The MELT Method
The core objective of simplifying weight management for diabetics in Ontario is what gave birth to The MELT Method.
At The MELT Method, we understand the struggles of people trying to lose weight with type 2 diabetes. The MELT Method’s team of weight loss physicians and diabetes educators provide you with proven medication prescriptions, lifestyle modification, dietary education, fitness regimens and behavioral counselling to get you on the right path to losing weight with type 2 diabetes. It’s only when you get a personalized weight loss plan that the needle on the weight scale finally starts to move back.
The best bit? The MELT Method offers fully OHIP-covered weight loss consultation, along with free delivery of your weight loss meds, discreetly packaged and delivered direct to your door anywhere in Ontario.
Hold On, Can My Own Medication Be The Problem?
Diabetes and weight gain often go hand-in-hand. Plus, a few of the workhorse diabetes drugs, insulin among them, plus the older sulfonylureas, carry weight gain as a side effect. So you can do everything by the book and still feel like your own prescription is undoing it behind your back. Diabetes and weight gain travel together far more than people expect. None of this is a reason to stop taking anything. It’s a reason to raise it with your doctor. There are newer options that lower blood sugar without padding the scale, and sometimes one swap changes everything. If you wanna lose weight with type 2 diabetes, getting in touch with The MELT Method will be one of the best life-transforming decisions you’ll ever take.
How Much Do You Actually Have To Lose?
Less than you’re dreading. Nobody’s asking you to get back to your high-school weight.
Diabetes Canada pegs losing about 5% to 10% of your current body weight as being better for insulin sensitivity, blood sugar, and blood pressure. On a 200-pound frame, that’s 10 to 20 pounds. Not 70. The American Diabetes Association’s 2026 standards say pretty much the same, landing around 5% to 7%.
“A 5–10% loss changes more than people expect, and it happens fast. Blood sugar drops within weeks, blood pressure often follows within a month or two, and triglycerides and liver markers can improve dramatically — because visceral fat is the first to go. But the part patients actually notice first is the energy, the sleep, and the joint pain easing up. The bloodwork moves before the mirror does, and that’s what we tell people to watch.”
-Khalid Bhatti, Director of Pharmacy & Diabetes Education, Durham Care Clinic + Pharmacy
Bigger losses, held onto, can do something that still catches people off guard. The DiRECT trial pushed nearly half its participants into remission at one year. Remission as in normal blood sugar, off the diabetes meds. What mattered most was how much they lost and kept off, and it worked best early in the disease.
That’s what The MELT Method was built for; helping people lose weight with type 2 diabetes – the right way and to the right amount.
Where Ozempic And The GLP-1s Fit
You know the name already. Semaglutide and the rest of the GLP-1 receptor agonists shook up how the whole field thinks about weight loss with type 2 diabetes, because they go at blood sugar and weight together.
When specifically talking about Ontario, Ozempic is approved to treat type 2 diabetes and to lower cardiovascular risk in certain patients, but not for weight management, even though doctors prescribe it off-label for weight constantly. The product actually approved for weight is a separate, higher-dose version under the name ‘Wegovy’. Curious how one drug does both jobs? We get into the mechanics in our explainer on how GLP-1 medications work. Just know they do their best work when paired with exercise, nutrition and lifestyle habit modifications.
The good news? Generic Semaglutide just got approved by Health Canada and the prices have come way down. At The MELT Method, we’re providing a month’s worth of Semaglutide for $99 and under, discreetly delivered to your doorstep for $0 delivery. All it requires is an OHIP-covered consultation with our weight management physicians.
Time for Some Myth-Busting
What’s the single biggest piece of misinformation your diabetes patients arrive with about weight loss?
That type 2 diabetes is permanent and only ever gets worse — so weight loss is about “damage control” rather than something that can fundamentally change the disease. They’ve been told to manage it, never that meaningful weight loss can put it into remission. That belief quietly lowers everyone’s ambition.
The second-biggest myth is that they “did this to themselves” — the shame framing — which is both wrong and counterproductive.
People hear “remission” and think “cure.” How do you explain the difference without killing their motivation?
We’re honest and we keep it hopeful. Remission means your blood sugar is back in the normal range and staying there without diabetes medication — by consensus, an A1C below 6.5% sustained for at least three months off glucose-lowering drugs. That’s a genuine, life-changing milestone.
The reason we don’t call it a cure is that the underlying tendency is still there. If the weight comes back, the diabetes can come back — which is exactly why we keep monitoring even after someone is doing great. We frame it like this: remission isn’t the finish line — it’s a state you get to keep maintaining. And that’s good news, because it means it’s in your hands.
That framing protects motivation. Patients hear “I can get there and I can stay there,” not “I’m broken forever” and not “I’m cured, I can stop.”
Is there advice that’s technically true but that you think does more harm than good for this group?
“Just eat less and move more.” It’s not false — energy balance is real — but as advice, it’s close to useless and often harmful for this group. It implies the only missing ingredient is effort, which loads blame onto people who are already trying hard, and it ignores everything we actually treat: insulin resistance, medications, sleep, hormones, metabolic adaptation, and the biology that defends old weight.
People have usually “eaten less and moved more” many times. Telling them to do it harder is why so many arrive ashamed and convinced they’re the problem. The honest version is: the strategy matters more than the effort, and we change the strategy to match your physiology.
What Good Care Looks Like Here
The part that people looking to lose weight with insulin resistance struggle with is this: They’ve got the target but not the roadmap. Weight management for diabetics in Ontario, done right, is not a juice cleanse or a one-pager from a ten-minute appointment. It’s oversight, a plan that respects the medications you already take, and someone tracking your numbers as they move. And they will move, sometimes enough that your doses come down.
Money is the other quiet blocker. Plenty of patients assume it’s all out of pocket and never ask. Before you write it off, check this: some of that care falls under OHIP covered weight loss programs.
The Hard Part About Weight Loss Comes After Weight Loss
Losing weight is one thing. Keeping the weight from coming back is another ball game. This is where most plans quietly fall apart because keeping your weight down takes building healthy habits that feel like the ‘new normal’ rather than a goal to check off your bucket list.
When you drop weight, your body pushes back to get back to the same level. It burns a touch less cals, turns hunger up a notch, and waits for you to slip. Getting past that takes an actual plan, which is what we lay out in our piece onmaintaining weight loss. With diabetes there’s a bonus: hold the loss steady and the blood sugar also starts to stabilize.
If you’re tired of watching weight loss transformation videos and feel like this is the year you’re going to take charge of your health and weight, get in touch with us. We pair proven weight loss meds with healthy lifestyle, exercise, and behavioral regimens to not only help you lose weight fast, but also help you build habits that keep you from gaining that weight back. The first consultation is free and 100% OHIP-covered. What excuse do you have now?
Frequently Asked Questions
1. Can losing weight reverse type 2 diabetes?
For some people, yes. Sustained weight loss has tipped type 2 diabetes into remission in trials, with the best odds in the first few years after diagnosis. Not a cure, and not everyone gets there. But blood sugar usually improves as the weight does.
2. What is the best diet for weight loss with type 2 diabetes?
The one you’ll still be following in six months. When researchers line the popular diets up against each other, the differences mostly wash out by the one-year mark. So pick something you can live with. Whole foods, more fibre, steadier carbs.
3. Which weight loss medications are safe for diabetics in Canada?
Several GLP-1 options are approved here. Whether one of them suits you comes down to your other conditions and medications, and that’s a call for your prescriber, not Google.
4. Does Ozempic help with weight loss in type 2 diabetes?
In the trials it did, alongside steadier blood sugar. How much depends on the person and the dose. It’s a prescription, used with medical supervision.
5. How much weight do you need to lose to improve blood sugar?
Often surprisingly little. A 5% to 10% drop is enough to shift insulin sensitivity and blood sugar for a lot of people.
6. Is the MELT Method suitable for people with diabetes?
Yes, and the medical oversight is the whole point. We build the plan around the treatment you’re already on. Start with a conversation about your goals and your current meds.
Expert Q&A With Khalid Bhatti
In your own patients, what’s the most common reason weight loss stalls that has nothing to do with effort? Anything that surprised you early in your career?
The single biggest one we see is sleep — specifically short or fragmented sleep, and undiagnosed sleep apnea, which is enormously common in this population and frequently missed. A patient doing everything right on food and movement but sleeping five broken hours a night is fighting their own physiology: appetite hormones shift (ghrelin up, leptin down), insulin resistance worsens overnight, and cortisol stays elevated. They’re not failing the plan — the plan is being run on a body that’s stuck in survival mode.
Right behind sleep are three quiet stallers: medications working against them (more on that below), under-treated hypothyroidism or perimenopause, and — the one that surprises people — the body’s own defense of its old weight. After any meaningful loss, resting metabolic rate drops more than the weight loss alone predicts, and hunger hormones rise. This “metabolic adaptation” is real, and it is not a willpower problem.
What surprised me early in my career was how predictable the stall is, and how often patients had been blamed for it. I expected weight loss to be roughly linear if someone stuck to the plan. It isn’t. The plateau is the body doing exactly what it evolved to do. Once I started naming that out loud — “this is biology, not failure” — patients stopped quitting at the plateau, which is precisely where most people give up.
When someone loses that first 5–10%, what shifts do you see in their bloodwork or how they feel, and how fast?
This is the most encouraging stretch of the whole journey, and it happens faster than people expect — often well before the mirror catches up.
What we typically see with a 5–10% loss:
Blood sugar and A1C: Meaningful drops in fasting glucose within weeks. A1C improving over the following three months (A1C lags because it reflects roughly three months of averages). For many type 2 patients, a 5–10% loss is enough to pull A1C out of the diabetic range or reduce medication needs.
Blood pressure: Often down within the first month or two, sometimes enough to revisit blood pressure medication.
Triglycerides and liver: Triglycerides fall quickly. Markers of fatty liver (ALT, and on imaging) improve, often dramatically, because visceral and liver fat are the first to mobilize.
Energy, joints, sleep: Patients report better energy, less joint pain, and improved sleep within the first few weeks — frequently before a big number change on the scale.
The before/after pattern that’s gold: someone arrives with an A1C around 7.5–8%, fasting glucose in the high single digits (mmol/L), elevated triglycerides and ALT, snoring and daytime fatigue. Eight to twelve weeks and a 6–8% loss later: fasting glucose noticeably lower, triglycerides down, ALT trending to normal, blood pressure improved, and — the part they actually feel — sleeping through the night and not crashing at 3 p.m. The bloodwork moves first. The scale and the mirror catch up later. We tell patients to watch the labs and the energy, not just the scale.
Roughly what share of your type 2 patients are on a medication that’s quietly working against their weight, and what happens after you flag it to their physician?
A meaningful share — in our experience, commonly a quarter to a third of newly referred type 2 patients — are on at least one medication that promotes weight gain or blocks weight loss. The usual suspects:
Insulin and sulfonylureas (e.g., gliclazide, glyburide) — classic culprits.
Some older anti-hyperglycemics versus weight-favorable newer agents.
Certain antidepressants and antipsychotics (e.g., mirtazapine, some SSRIs, olanzapine, quetiapine).
Beta-blockers, gabapentin/pregabalin, and chronic oral steroids.
When we flag it to the physician, the conversation is almost always productive — most prescribers are glad to have it surfaced. Where clinically appropriate, swapping toward weight-neutral or weight-favorable alternatives can restart stalled progress, sometimes without the patient changing a single thing about their diet. The key point for patients: never stop or change a prescription on your own — this is a coordinated conversation with the prescriber.
What do you tell a patient who walks in asking specifically for Ozempic to lose weight? Where does it genuinely help, and where do you push back?
First, we don’t dismiss it — the science is strong and the interest is reasonable. Then we slow it down. GLP-1 medications (semaglutide and others) genuinely help: they reduce appetite and “food noise,” improve blood sugar, and produce weight loss that’s hard to achieve any other way for many people. For type 2 patients, there are cardiovascular and kidney benefits beyond the weight itself.
Where we push back: the medication is a tool, not a plan. Without attention to protein, resistance training to protect muscle, sleep, and the behavioral side, people lose more muscle than they should and set themselves up to regain when they stop. We also right-size expectations and talk honestly about cost and coverage in Ontario before anyone gets attached.
And it’s a medical decision. Ozempic specifically is approved for type 2 diabetes. Wegovy is the semaglutide product approved for weight management. The product, the indication, and the candidacy all need a proper assessment — not a pharmacy counter request.
What’s the most common mistake people make with GLP-1s on their own, without supervision?
Treating it as a standalone fix and skipping the scaffolding — not eating enough protein, not doing resistance training, and not having a plan for the inevitable question of “what happens when I stop.” The result is muscle loss disguised as success on the scale, and rapid regain later.
The other common unsupervised mistake is dose and side-effect mismanagement: ramping too fast (nausea, dehydration, sometimes ER visits), or buying from grey-market or compounded sources where dose and purity aren’t guaranteed. Supervision is what turns a powerful drug into a durable result.
After someone stops a GLP-1, what actually happens, and how do you plan for it?
Appetite comes back, “food noise” returns, and without a plan, weight tends to come back — studies consistently show significant regain after stopping. This is not a personal failure. It’s the drug no longer doing what it was doing. We’re upfront about it from day one so it’s never a surprise.
Planning for it means deciding early whether this is long-term therapy — for many, like other chronic-disease medications, it is — or a bridge. If it’s a bridge, we build the off-ramp before we need it: muscle banked through resistance training, protein and eating habits locked in, sleep handled, and sometimes a slower taper rather than an abrupt stop, with close monitoring through the transition.
The patients who do best are the ones who used the medication’s “quiet appetite” window to build habits that outlast the prescription.
What do most Ontario patients not understand about what’s covered versus out of pocket?
The biggest misunderstanding: people assume that because OHIP covers their doctor, their weight-loss medication is covered too. It usually isn’t. OHIP covers physician visits, not outpatient prescription drugs. Drug coverage runs through the Ontario Drug Benefit (ODB) program — for seniors, ODSP/OW recipients, and others — or through private insurance.
And critically: in Ontario, GLP-1s are covered for type 2 diabetes, not for weight loss. Ozempic is covered through ODB only under Limited Use criteria for adults with type 2 diabetes (broadly, those who haven’t reached targets on metformin) — and since early 2024 it is no longer a general benefit, specifically to preserve supply for diabetes and exclude weight-management-only use. Wegovy — the semaglutide product indicated for weight management — is not publicly covered in Ontario. Pan-Canadian price negotiations with the manufacturer ended in December 2025 without a deal, so it remains out of pocket or dependent on private plans.
For a patient without diabetes, weight-management GLP-1 therapy is, for now, largely a private-pay or private-insurance question. This is exactly the gap most national and US blogs get wrong.
With generic semaglutide now approved in Canada, what’s changed for your patients in practice?
This is a real shift. Canada became the first G7 country to approve generic semaglutide — Health Canada authorized a first generic (Dr. Reddy’s) in April 2026 and a second (Apotex) shortly after, with the product reaching pharmacies in May 2026. Two practical points for patients:
It’s the Ozempic indication first, not Wegovy. The current generics are equivalents to Ozempic (type 2 diabetes), not to Wegovy’s higher-dose weight-management formulation, which is still protected by additional patents. So the immediate winners are diabetes patients, not weight-management-only patients.
Cheaper, but gradually. Under pan-Canadian pricing rules, the first generic typically lands around 75–85% of brand price, dropping toward roughly 50% with a second entrant and roughly 35% once three or more are available. Expect prices to fall in steps over the coming months rather than overnight.
For our patients, the headline is: cost is starting to come down, access is improving, but the weight-management product picture in Ontario hasn’t fully changed yet.
How does OHIP-covered care actually change outcomes versus someone going it alone?
The medication gets the headlines, but the care wrapped around it is what changes outcomes — and that’s where covered, physician-led care matters. With a publicly funded clinical team, the diabetes itself is managed properly: medications reviewed (including the ones working against the patient), labs monitored, sleep apnea and thyroid caught, complications screened, and the plan adjusted over time.
Someone going it alone — buying a drug online, no monitoring — gets the appetite effect but none of the safety net. No one catching a coverage pathway they qualify for. No one protecting their muscle. No one managing the come-down if they stop. The covered, coordinated version is safer, cheaper for the patient over time, and far more durable.
If you could get every newly diagnosed type 2 patient in Ontario to do one thing in the first year, what would it be and why?
Start resistance training — and start in the first year, not “someday.” The first year after diagnosis is a window where the disease is most responsive, and muscle is the most underrated organ in diabetes care: it’s where you burn glucose, it protects you on a GLP-1, and it’s the thing that makes any weight loss stick. Most newly diagnosed patients are told to “walk more.” Walking is great, but if I could pick one thing, it’s building muscle — it changes the trajectory of the whole disease, not just the number on the scale.
“The first year after a type 2 diagnosis is the most valuable year you’ll ever have with this disease — what you build then, especially muscle, decides how the next twenty years go.”
What’s a small win you’ve watched change someone’s whole trajectory?
The one I come back to: a patient who’d quit at every plateau for years finally stuck past one, hit a 7% loss, came off one of their diabetes medications, and — the part that actually changed everything — slept through the night for the first time in years. That one full night of sleep did more for their motivation than any lab result. They came in the next visit saying “I forgot what it felt like to not be exhausted.” From there, everything got easier, because they were finally fighting the disease with a rested body instead of an exhausted one.
The small win wasn’t the 7% — it was the sleep. And watching it cascade into everything else.
“Sometimes the win that changes everything isn’t on the scale or the lab report — it’s the first full night of sleep in years. That’s when people stop white-knuckling it and start actually living the change.”